Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

Go back to Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 9.27 +2.18 (30.75%)
Previous Close $7.09    52 Week High $9.58 
Open $7.18    52 Week Low $2.34 
Day High $9.72    P/E N/A 
Day Low $7.17    EPS $-0.34 
Volume 188,676